PTEN loss is associated with worse outcome in HER2-Amplified breast cancer patients but is not associated with trastuzumab resistance

  1. Stern, H.M.
  2. Gardner, H.
  3. Burzykowski, T.
  4. Elatre, W.
  5. O'Brien, C.
  6. Lackner, M.R.
  7. Pestano, G.A.
  8. Santiago, A.
  9. Villalobos, I.
  10. Eiermann, W.
  11. Pienkowski, T.
  12. Martin, M.
  13. Robert, N.
  14. Crown, J.
  15. Nuciforo, P.
  16. Bee, V.
  17. Mackey, J.
  18. Slamon, D.J.
  19. Press, M.F.
Revista:
Clinical Cancer Research

ISSN: 1557-3265 1078-0432

Any de publicació: 2015

Volum: 21

Número: 9

Pàgines: 2065-2074

Tipus: Article

DOI: 10.1158/1078-0432.CCR-14-2993 GOOGLE SCHOLAR